Gilead’s remdesivir takes center stage for now but HIV drugs make up majority of sales By: MarketWatch April 24, 2020 at 15:13 PM EDT If this pandemic is going to have a savior, investors are betting that Gilead Sciences Inc. is their personal Jesus. Read More >> Related Stocks: Gilead Sciences